Study of monkeypox infection in Brazil
Part of Infections clinical trials.
This is an observational study that follows people with confirmed monkeypox (mpox) to better understand the illness over time. It may help doctors learn what to expect and improve care, but it does not test a new treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old
- Have confirmed mpox infection from a lab test (PCR, culture, or antigen test)
- The sample used for the test should be taken within about 4 days of starting the study
- Be able to give informed consent (agree to join after understanding the study)
- Be able to do follow-up in a decentralized way (follow-up that doesn’t require staying only in one place)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment for mpox (monkeypox) in people with active sores. It aims to see if the treatment helps clear the infection faster and reduce symptoms.
This observational study looks at how your body’s defenses work against mpox (monkeypox), based on blood and health information. You may be eligible if you recently got an mpox vaccine or have had mpox infection and are now out of isolation.
This study in West Africa follows people with confirmed mpox (monkeypox) infection and their close contacts to understand how the virus spreads, clears from the body, and how well the mpox vaccine protects people. You may be eligible if you've recently tested positive for mpox, were exposed to someone with mpox, or live in an area offering mpox vaccination.
This is an observational study that follows adults after they get a monkeypox vaccine to learn how their immune system responds. The results may help researchers understand what types of protection the vaccine creates.
This study follows people after confirmed mpox, after smallpox vaccination, or in people taking HIV PrEP to learn how the immune system responds over time. It may help scientists better understand protection and immune changes after these exposures.
This study looks at how well the mpox vaccine works during outbreaks. It tracks people who may have been exposed, those who have been vaccinated or already had mpox, and healthy volunteers.
Hear when a new Monkeypox trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.